Comparative Effects of Nicorandil, Isosorbide Mononitrate, and Diltiazem on Radial Artery Graft Patency After CABG: Insights from the ASRAB-Pilot Trial
Highlight
- Nicorandil and isosorbide mononitrate treatment post-CABG associated with lower radial artery (RA) graft failure rates than diltiazem at 24 weeks.
- At 1 week post-surgery, nicorandil and isosorbide mononitrate showed trends toward reduced graft failure compared to diltiazem, though differences were not statistically significant.
- This pilot randomized trial provides important comparative data to guide selection of antispastic agents after CABG with RA grafts.
- Larger hypothesis-testing trials are necessary to validate these encouraging findings and inform clinical guidelines.
Study Background and Disease Burden
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.